FDA Reverses Course, Approves China’s Equivalent Of The N95 Mask To Protect Against Coronavirus

France Nouvelles Nouvelles

FDA Reverses Course, Approves China’s Equivalent Of The N95 Mask To Protect Against Coronavirus
France Dernières Nouvelles,France Actualités
  • 📰 Forbes
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 53%

The FDA originally left the Chinese masks off the list of approved respirators over concerns about fraudulent products.

: Healthcare workers, along with state and local officials, have been sounding the alarm over a dangerous shortage of essential equipment protecting nurses and doctors on the frontlines, such as masks, gowns and gloves. The situation has gotten so dire that healthcare workers in New York are

masks only meant for a single use. As a result, the mask market has been thrown into chaos, with prices continuing to increase as countries and U.S. states battle for the same limited supply.: The U.S. is experiencing the worst outbreak of the coronavirus in the world with more than 266,000 cases. Public health officials have said the peak in cases will hit next week.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

Forbes /  🏆 394. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

In A Reversal, The FDA Now Approves KN95 Masks For Emergency UseIn A Reversal, The FDA Now Approves KN95 Masks For Emergency UseThe move, which allows the Chinese equivalent of N95 masks to be imported and used by health care workers, is designed to alleviate desperate shortages of personal protective equipment.
Lire la suite »

FDA Supports Effort To Develop COVID Treatment From Plasma Of Recovered PatientsFDA Supports Effort To Develop COVID Treatment From Plasma Of Recovered PatientsThe Food and Drug Administration announced Friday that it will take charge of a program that includes the Mayo Clinic and the American Red Cross with funds from the federal government.
Lire la suite »

The FDA Pulls Heartburn Drug Zantac From Stores Amid Carcinogen ConcernsThe FDA Pulls Heartburn Drug Zantac From Stores Amid Carcinogen ConcernsThe carcinogen NDMA was found in ranitidine (Zantac), with levels increasing dangerously over time and in high storage temperatures.
Lire la suite »

FDA orders all Zantac heartburn products off store shelvesFDA orders all Zantac heartburn products off store shelvesAll Zantac products and generic versions of the heartburn medication should be taken off pharmacy shelves immediately, FDA says.
Lire la suite »

FDA says there's a shortage of hydroxychloroquine and chloroquine 'due to a significant surge in demand'FDA says there's a shortage of hydroxychloroquine and chloroquine 'due to a significant surge in demand'The drugs are being used experimentally to treat COVID-19 patients.
Lire la suite »

FDA Says Zantac Should Be Pulled From Market, Citing Cancer RiskFDA Says Zantac Should Be Pulled From Market, Citing Cancer RiskMajor pharmacies had already pulled the popular heartburn drug and its generic equivalents due to a contaminant. Now the Food and Drug Administration says definitively they should not be sold or used.
Lire la suite »



Render Time: 2025-04-01 22:17:24